Clinical Trial Update: A Study to Evaluate P1101 in Japanese PV Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating P1101 in Japanese patients with Polycythemia Vera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• P1101

Snippet

Sponsor: PharmaEssentia Japan K.K. | Conditions: Polycythemia Vera (PV) | Phase 3 | Status: COMPLETED